The panel / Screening and safety
Mood screen
Depression in men frequently does not look like sadness. It looks like fatigue, irritability, anger, withdrawal and a libido that has gone. That is the same list that brings men to a testosterone clinic, which is precisely why this screen is here and why so few places doing this work bother with it.
What it measures
The PHQ-9 is a nine-item validated questionnaire covering mood, interest, sleep, energy, appetite, concentration, self-worth and thoughts of self-harm. It is used both to screen and to track severity over time.
In the TRAVERSE trial, a PHQ-9 above 4 was used to mark significant depressive symptoms, and 50.8 percent of the hypogonadal men met that threshold. Half. That is the scale of the overlap this screen exists to handle.
Why it is on the panel
Because the symptom overlap is near total and the treatments are different. A man whose fatigue and low libido come from depression will not be fixed by testosterone, and sending him away with a protocol and a sense that the problem is handled is an active harm. It also matters in the other direction, since antidepressants themselves cause sexual dysfunction, which changes the conversation.
Interpretation
Reading the result
The score guides the conversation rather than producing a label on its own.
What complicates the picture
What happens next
A positive screen is discussed directly rather than filed. Being handed a testosterone protocol instead is the failure mode this exists to prevent.
The rest of the panel is read alongside it, because thyroid disease, sleep apnoea and iron deficiency all produce depressive symptoms.
Where an antidepressant is already the cause of sexual side effects, that is reviewed with whoever prescribes it rather than worked around.
Where treatment is indicated, we refer or coordinate. We do not treat depression here, and saying so is better than pretending otherwise.